Bedrocan: What Went Wrong? – The Administrators’ Account
This is the final part of our three-part series examining the various, conflicting accounts of Bedrocan’s bankruptcy declaration.
This is the final part of our three-part series examining the various, conflicting accounts of Bedrocan’s bankruptcy declaration.
Policy, markets and medical news from the newsroom, in one email a week.
Sign up freeLast week, the first Cannabis Health Symposium to take place in Germany saw the local industry’s leading telemedicine and pharmacy voices pull apart the rationale behind proposed medical cannabis restrictions.
Read the analysisEurope’s largest medical cannabis market, tracked by our newsroom week by week.
Since the implementation of the MedCanG in April 2024, the German medical cannabis market has become a key target for regional and international cannabis operators alike.
countries we track allow adult-use cannabis. 25 run established medical programmes.
Explore the mapCannabis stocks43listed cannabis stocks tracked across MSOs, LPs, ancillary, pharma, REITs and ETFs.
Open the trackerUS reschedulingSince 197030 dated milestones in the federal process, from the Controlled Substances Act to today.
Follow the timeline